Medicus Pharma (MDCX) Competitors $1.83 -0.16 (-8.04%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock MDCX vs. CRDF, FBRX, CABA, GNLX, ZURA, CHRS, IKT, ACOG, BHST, and CGENShould you be buying Medicus Pharma stock or one of its competitors? The main competitors of Medicus Pharma include Cardiff Oncology (CRDF), Forte Biosciences (FBRX), Cabaletta Bio (CABA), Genelux (GNLX), Zura Bio (ZURA), Coherus Oncology (CHRS), Inhibikase Therapeutics (IKT), Alpha Cognition (ACOG), BioHarvest Sciences (BHST), and Compugen (CGEN). These companies are all part of the "pharmaceutical products" industry. Medicus Pharma vs. Its Competitors Cardiff Oncology Forte Biosciences Cabaletta Bio Genelux Zura Bio Coherus Oncology Inhibikase Therapeutics Alpha Cognition BioHarvest Sciences Compugen Medicus Pharma (NASDAQ:MDCX) and Cardiff Oncology (NASDAQ:CRDF) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, media sentiment, risk, dividends, profitability and institutional ownership. Do institutionals and insiders have more ownership in MDCX or CRDF? 16.3% of Cardiff Oncology shares are held by institutional investors. 11.2% of Medicus Pharma shares are held by insiders. Comparatively, 7.7% of Cardiff Oncology shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts recommend MDCX or CRDF? Medicus Pharma currently has a consensus price target of $23.50, indicating a potential upside of 1,184.15%. Cardiff Oncology has a consensus price target of $10.10, indicating a potential upside of 374.18%. Given Medicus Pharma's stronger consensus rating and higher probable upside, equities analysts clearly believe Medicus Pharma is more favorable than Cardiff Oncology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medicus Pharma 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50Cardiff Oncology 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Is MDCX or CRDF more profitable? Medicus Pharma has a net margin of 0.00% compared to Cardiff Oncology's net margin of -9,344.14%. Cardiff Oncology's return on equity of -77.94% beat Medicus Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Medicus PharmaN/A -549.30% -228.06% Cardiff Oncology -9,344.14%-77.94%-63.65% Does the media prefer MDCX or CRDF? In the previous week, Cardiff Oncology had 1 more articles in the media than Medicus Pharma. MarketBeat recorded 5 mentions for Cardiff Oncology and 4 mentions for Medicus Pharma. Cardiff Oncology's average media sentiment score of 0.79 beat Medicus Pharma's score of 0.12 indicating that Cardiff Oncology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medicus Pharma 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cardiff Oncology 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, MDCX or CRDF? Medicus Pharma has higher earnings, but lower revenue than Cardiff Oncology. Cardiff Oncology is trading at a lower price-to-earnings ratio than Medicus Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedicus PharmaN/AN/A-$11.16M-$1.34-1.37Cardiff Oncology$680K208.40-$45.43M-$0.87-2.45 SummaryCardiff Oncology beats Medicus Pharma on 8 of the 15 factors compared between the two stocks. Get Medicus Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MDCX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDCX vs. The Competition Export to ExcelMetricMedicus PharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$35.45M$3.13B$5.75B$9.85BDividend YieldN/A2.28%6.67%4.51%P/E Ratio-1.3720.8978.4326.42Price / SalesN/A458.96546.94119.09Price / CashN/A44.5237.0558.92Price / Book6.319.9310.916.06Net Income-$11.16M-$53.38M$3.29B$266.28M7 Day Performance-8.50%0.05%0.01%-0.76%1 Month Performance-23.11%7.08%7.06%3.83%1 Year PerformanceN/A11.92%50.09%24.39% Medicus Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDCXMedicus Pharma1.777 of 5 stars$1.83-8.0%$23.50+1,184.2%N/A$35.45MN/A-1.37N/AAnalyst ForecastCRDFCardiff Oncology2.8078 of 5 stars$2.18+0.2%$10.10+364.4%-10.5%$144.70M$680K-2.5020FBRXForte Biosciences3.5154 of 5 stars$11.30+1.3%$68.00+501.8%+44.0%$140.45MN/A-0.695Positive NewsOptions VolumeCABACabaletta Bio2.0222 of 5 stars$1.54+2.3%$14.43+840.0%-69.0%$139.48MN/A-0.5650News CoveragePositive NewsGNLXGenelux1.246 of 5 stars$3.67+0.7%$20.33+454.8%+59.1%$138.43M$10K-4.2610News CoverageZURAZura Bio3.0687 of 5 stars$2.13-1.6%$14.00+558.8%-50.2%$136.87MN/A-3.013News CoverageCHRSCoherus Oncology4.1425 of 5 stars$1.16+1.8%$4.68+303.7%-7.4%$135.41M$266.96M0.75330News CoverageAnalyst UpgradeGap UpIKTInhibikase Therapeutics1.7743 of 5 stars$1.82+1.4%$6.50+258.1%+29.1%$133.76MN/A-0.676ACOGAlpha Cognition2.517 of 5 stars$8.24flat$20.00+142.7%N/A$133.16MN/A-5.15N/AGap DownBHSTBioHarvest SciencesN/A$8.06-4.0%$13.67+69.6%N/A$132.35M$25.19M-11.51N/APositive NewsGap DownCGENCompugen2.5435 of 5 stars$1.47-0.3%$4.00+173.0%-26.0%$131.54M$27.86M-6.7070Positive NewsShort Interest ↓ Related Companies and Tools Related Companies Cardiff Oncology Alternatives Forte Biosciences Alternatives Cabaletta Bio Alternatives Genelux Alternatives Zura Bio Alternatives Coherus Oncology Alternatives Inhibikase Therapeutics Alternatives Alpha Cognition Alternatives BioHarvest Sciences Alternatives Compugen Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MDCX) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicus Pharma Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicus Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDCX Stock Alerts